Bright Minds Biosciences (DRUG) Shares Outstanding (Weighted Average): 2020-2021

Historic Shares Outstanding (Weighted Average) for Bright Minds Biosciences (DRUG) over the last 1 years, with Sep 2021 value amounting to $2.4 million.

  • Bright Minds Biosciences' Shares Outstanding (Weighted Average) rose 20.47% to $2.4 million in Q3 2021 from the same period last year, while for Jun 2021 it was $2.0 million, marking a year-over-year change of. This contributed to the annual value of $4.5 million for FY2024, which is 18.34% up from last year.
  • According to the latest figures from Q3 2021, Bright Minds Biosciences' Shares Outstanding (Weighted Average) is $2.4 million, which was up 20.47% from $2.0 million recorded in Q2 2021.
  • Bright Minds Biosciences' 5-year Shares Outstanding (Weighted Average) high stood at $2.4 million for Q3 2021, and its period low was $2.0 million during Q3 2020.
  • For the 2-year period, Bright Minds Biosciences' Shares Outstanding (Weighted Average) averaged around $2.0 million, with its median value being $2.0 million (2021).
  • Data for Bright Minds Biosciences' Shares Outstanding (Weighted Average) shows a peak YoY grew of 20.47% (in 2021) over the last 5 years.
  • Bright Minds Biosciences' Shares Outstanding (Weighted Average) (Quarterly) stood at $2.0 million in 2020, then rose by 20.47% to $2.4 million in 2021.
  • Its Shares Outstanding (Weighted Average) was $2.4 million in Q3 2021, compared to $2.0 million in Q2 2021 and $2.0 million in Q1 2021.